@article{RN139,
   author = {Aycock, K. N. and Davalos, R. V.},
   title = {Irreversible Electroporation: Background, Theory, and Review of Recent Developments in Clinical Oncology},
   journal = {Bioelectricity},
   volume = {1},
   number = {4},
   pages = {214-234},
   note = {2576-3113
Aycock, Kenneth N
Davalos, Rafael V
Journal Article
Review
United States
2019/12/01
Bioelectricity. 2019 Dec 1;1(4):214-234. doi: 10.1089/bioe.2019.0029. Epub 2019 Dec 12.},
   abstract = {Irreversible electroporation (IRE) has established a clinical niche as an alternative to thermal ablation for the eradication of unresectable tumors, particularly those near critical vascular structures. IRE has been used in over 50 independent clinical trials and has shown clinical success when used as a standalone treatment and as a single component within combinatorial treatment paradigms. Recently, many studies evaluating IRE in larger patient cohorts and alongside other novel therapies have been reported. Here, we present the basic principles of reversible electroporation and IRE followed by a review of preclinical and clinical data with a focus on tumors in three organ systems in which IRE has shown great promise: the prostate, pancreas, and liver. Finally, we discuss alternative and future developments, which will likely further advance the use of IRE in the clinic.},
   keywords = {electroporation
interventional oncology
irreversible electroporation
pulsed electric field},
   ISSN = {2576-3105 (Print)
2576-3105},
   DOI = {10.1089/bioe.2019.0029},
   year = {2019},
   type = {Journal Article}
}

{"_id":"odef3ZJQZd9obSThu","bibbaseid":"aycock-davalos-irreversibleelectroporationbackgroundtheoryandreviewofrecentdevelopmentsinclinicaloncology-2019","author_short":["Aycock, K. N.","Davalos, R. V."],"bibdata":{"bibtype":"article","type":"Journal Article","author":[{"propositions":[],"lastnames":["Aycock"],"firstnames":["K.","N."],"suffixes":[]},{"propositions":[],"lastnames":["Davalos"],"firstnames":["R.","V."],"suffixes":[]}],"title":"Irreversible Electroporation: Background, Theory, and Review of Recent Developments in Clinical Oncology","journal":"Bioelectricity","volume":"1","number":"4","pages":"214-234","note":"2576-3113 Aycock, Kenneth N Davalos, Rafael V Journal Article Review United States 2019/12/01 Bioelectricity. 2019 Dec 1;1(4):214-234. doi: 10.1089/bioe.2019.0029. Epub 2019 Dec 12.","abstract":"Irreversible electroporation (IRE) has established a clinical niche as an alternative to thermal ablation for the eradication of unresectable tumors, particularly those near critical vascular structures. IRE has been used in over 50 independent clinical trials and has shown clinical success when used as a standalone treatment and as a single component within combinatorial treatment paradigms. Recently, many studies evaluating IRE in larger patient cohorts and alongside other novel therapies have been reported. Here, we present the basic principles of reversible electroporation and IRE followed by a review of preclinical and clinical data with a focus on tumors in three organ systems in which IRE has shown great promise: the prostate, pancreas, and liver. Finally, we discuss alternative and future developments, which will likely further advance the use of IRE in the clinic.","keywords":"electroporation interventional oncology irreversible electroporation pulsed electric field","issn":"2576-3105 (Print) 2576-3105","doi":"10.1089/bioe.2019.0029","year":"2019","bibtex":"@article{RN139,\n author = {Aycock, K. N. and Davalos, R. V.},\n title = {Irreversible Electroporation: Background, Theory, and Review of Recent Developments in Clinical Oncology},\n journal = {Bioelectricity},\n volume = {1},\n number = {4},\n pages = {214-234},\n note = {2576-3113\nAycock, Kenneth N\nDavalos, Rafael V\nJournal Article\nReview\nUnited States\n2019/12/01\nBioelectricity. 2019 Dec 1;1(4):214-234. doi: 10.1089/bioe.2019.0029. Epub 2019 Dec 12.},\n abstract = {Irreversible electroporation (IRE) has established a clinical niche as an alternative to thermal ablation for the eradication of unresectable tumors, particularly those near critical vascular structures. IRE has been used in over 50 independent clinical trials and has shown clinical success when used as a standalone treatment and as a single component within combinatorial treatment paradigms. Recently, many studies evaluating IRE in larger patient cohorts and alongside other novel therapies have been reported. Here, we present the basic principles of reversible electroporation and IRE followed by a review of preclinical and clinical data with a focus on tumors in three organ systems in which IRE has shown great promise: the prostate, pancreas, and liver. Finally, we discuss alternative and future developments, which will likely further advance the use of IRE in the clinic.},\n keywords = {electroporation\ninterventional oncology\nirreversible electroporation\npulsed electric field},\n ISSN = {2576-3105 (Print)\n2576-3105},\n DOI = {10.1089/bioe.2019.0029},\n year = {2019},\n type = {Journal Article}\n}\n\n","author_short":["Aycock, K. N.","Davalos, R. V."],"key":"RN139","id":"RN139","bibbaseid":"aycock-davalos-irreversibleelectroporationbackgroundtheoryandreviewofrecentdevelopmentsinclinicaloncology-2019","role":"author","urls":{},"keyword":["electroporation interventional oncology irreversible electroporation pulsed electric field"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/network/files/bdNBTZRXTsoHCgpbh","dataSources":["D4zENc4BfFNBwSYYJ","ZPLjameRikygaiM9B","3XfNmZkLe6o8CvECW","fJQsxtBoqymHQG6tL","LzxgEApraxMPkLTMn","Z2THpXfLYEJf3CB8p"],"keywords":["electroporation interventional oncology irreversible electroporation pulsed electric field"],"search_terms":["irreversible","electroporation","background","theory","review","recent","developments","clinical","oncology","aycock","davalos"],"title":"Irreversible Electroporation: Background, Theory, and Review of Recent Developments in Clinical Oncology","year":2019}